| Literature DB >> 35056627 |
Patrick Waindok1, Elisabeth Janecek-Erfurth1, Dimitri L Lindenwald1, Esther Wilk2, Klaus Schughart2,3,4, Robert Geffers5, Christina Strube1.
Abstract
Toxocara canis and Toxocara cati are globally occurring zoonotic roundworms of dogs and cats. Migration and persistence of Toxocara larvae in the central nervous system of paratenic hosts including humans may cause clinical signs of neurotoxocarosis (NT). As pathomechanisms of NT and host responses against Toxocara larvae are mostly unknown, whole-genome microarray transcription analysis was performed in cerebra and cerebella of experimentally infected C57Bl/6J mice as paratenic host model at days 14, 28, 70, 98, and 120 post-infection. Neuroinvasion of T. cati evoked 220 cerebral and 215 cerebellar differentially transcribed genes (DTGs), but no particular PANTHER (Protein ANalysis THrough Evolutionary Relationships) pathway was affected. In T. canis-infected mice, 1039 cerebral and 2073 cerebellar DTGs were identified. Statistically significant dysregulations occurred in various pathways, including cholesterol biosynthesis, apoptosis signaling, and the Slit/Robo mediated axon guidance as well as different pathways associated with the immune and defense response. Observed dysregulations of the cholesterol biosynthesis, as well as the Alzheimer disease-amyloid secretase pathway in conjunction with previous histopathological neurodegenerative findings, may promote the discussion of T. canis as a causative agent for dementia and/or Alzheimer's disease. Furthermore, results contribute to a deeper understanding of the largely unknown pathogenesis and host-parasite interactions during NT, and may provide the basis for prospective investigations evaluating pathogenic mechanisms or designing novel diagnostic and therapeutic approaches.Entities:
Keywords: Alzheimer’s disease; cholesterol biosynthesis; differential transcription; gene transcription analysis; microarray; neural larva migrans; neurodegeneration; toxocariasis; toxocarosis
Year: 2022 PMID: 35056627 PMCID: PMC8779660 DOI: 10.3390/microorganisms10010177
Source DB: PubMed Journal: Microorganisms ISSN: 2076-2607
Figure 1Principal component analysis of transcriptional changes in cerebra and cerebella of T. canis- and T. cati-infected C57Bl/6J mice at different time points post-infection. To provide a better overview, all respective control mice are shown in black.
Figure 2Differentially transcribed genes identified in cerebra and cerebella of T. canis- and T. cati-infected mice over the course of infection.
Figure 3Venn diagram showing number and percentage of specific and overlapping differentially transcribed genes in T. canis- and T. cati-infected cerebra and cerebella.
Figure 4Transcriptional values of the five genes (a) Ighm, (b) Jchain, (c) Slpi, (d) Dnajc21, and (e) Rbm33 differentially transcribed in the cerebra and cerebella of both Toxocara. canis- and T. cati-mice at different days post infection (pi). Asterisks indicate statistically significant differences (p ≤ 0.05) between infected and uninfected mice according to the color scheme.
Pathways affected by differentially transcribed genes (DTGs) in T. canis-infected cerebra and cerebella. Note that no pathways were statistically significantly overrepresented during T. cati-infection.
| Enriched Biological Modules | DTGs | Fold-Enrichment | Adj. | |
|---|---|---|---|---|
| Cerebrum | Cholesterol biosynthesis (P00014) | 6 | 10.76 | 0.003 |
| Axon guidance mediated by Slit/Robo (P00008) | 7 | 6.80 | 0.005 | |
| B cell activation (P00010) | 13 | 4.33 | 0.001 | |
| T cell activation (P00053) | 14 | 3.63 | 0.003 | |
| Apoptosis signaling pathway (P00006) | 18 | 3.56 | 0.001 | |
| Interleukin signaling pathway (P00036) | 13 | 3.44 | 0.005 | |
| Ras Pathway (P04393) | 10 | 3.33 | 0.030 | |
| CCKR signaling map (P06959) | 21 | 3.08 | 0.001 | |
| Inflammation mediated by chemokine and cytokine signaling pathway (P00031) | 23 | 2.08 | 0.034 | |
| Unclassified | 790 | 0.93 | <0.001 | |
| Cerebellum | Apoptosis signaling pathway (P00006) | 25 | 2.54 | 0.006 |
| Inflammation mediated by chemokine and cytokine signaling pathway (P00031) | 44 | 2.04 | 0.004 | |
| Integrin signaling pathway (P00034) | 32 | 2.02 | 0.023 | |
| Unclassified | 1542 | 0.94 | <0.001 |
Number of differentially transcribed genes (DTGs) in Toxocara canis- and T. cati-infected cerebra and cerebella and enriched biological pathways with an adjusted p-value ≤ 0.05 for each study day.
| Study Day | Regulation | Number of DTGs | Enriched Biological Modules (PANTHER Pathway Accession Number) | |
|---|---|---|---|---|
|
| ||||
| cerebrum | 14 pi | up | 605 | Apoptosis signaling pathway (P00006), Axon guidance mediated by Slit/Robo (P00008), B-cell activation (P00010), CCKR signaling map (P06959), FAS signaling pathway (P00020), Inflammation mediated by chemokine and cytokine signaling pathway (P00031), Interleukin signaling pathway (P00036), JAK/STAT signaling pathway (P00038), Ras Pathway (P04393), T-cell activation (P00053) |
| down | 434 | Cholesterol biosynthesis (P00014) | ||
| 28 pi | up | 539 | Apoptosis signaling pathway (P00006), B-cell activation (P00010), CCKR signaling map (P06959), FAS signaling pathway (P00020), Inflammation mediated by chemokine and cytokine signaling pathway (P00031), Interleukin signaling pathway (P00036), JAK/STAT signaling pathway (P00038), Ras Pathway (P04393), T-cell activation (P00053) | |
| down | 500 | Cholesterol biosynthesis (P00014) | ||
| 70 pi | up | 534 | Apoptosis signaling pathway (P00006), Axon guidance mediated by Slit/Robo (P00008), B-cell activation (P00010), CCKR signaling map (P06959), FAS signaling pathway (P00020), Inflammation mediated by chemokine and cytokine signaling pathway (P00031), Interleukin signaling pathway (P00036), JAK/STAT signaling pathway (P00038), Ras Pathway (P04393), T-cell activation (P00053) | |
| down | 505 | Cholesterol biosynthesis (P00014) | ||
| 98 pi | up | 553 | Apoptosis signaling pathway (P00006), B-cell activation (P00010), CCKR signaling map (P06959), FAS signaling pathway (P00020), Inflammation mediated by chemokine and cytokine signaling pathway (P00031), Interleukin signaling pathway (P00036), JAK/STAT signaling pathway (P00038), Ras Pathway (P04393), T-cell activation (P00053) | |
| down | 486 | Cholesterol biosynthesis (P00014), Heterotrimeric G-protein signaling pathway-Gq alpha and Go alpha mediated pathway (P00026) | ||
| 120 pi | up | 621 | Apoptosis signaling pathway (P00006), Axon guidance mediated by Slit/Robo (P00008), B-cell activation (P00010), CCKR signaling map (P06959), Inflammation mediated by chemokine and cytokine signaling pathway (P00031), Interleukin signaling pathway (P00036), JAK/STAT signaling pathway (P00038), T-cell activation (P00053) | |
| down | 418 | 5HT2 type receptor-mediated signaling pathway (P04374), Alzheimer disease-amyloid secretase pathway (P00003), Cholesterol biosynthesis (P00014), Gonadotropin-releasing hormone receptor pathway (P06664), Heterotrimeric G-protein signaling pathway-Gq alpha and Go alpha mediated pathway (P00026) | ||
| cerebellum | 14 pi | up | 1106 | Apoptosis signaling pathway (P00006), B-cell activation (P00010), Inflammation mediated by chemokine and cytokine signaling pathway (P00031), Interleukin signaling pathway (P00036), Toll receptor signaling pathway (P00054) |
| down | 967 | n/a | ||
| 28 pi | up | 1139 | Apoptosis signaling pathway (P00006), B-cell activation (P00010), Inflammation mediated by chemokine and cytokine signaling pathway (P00031), Interleukin signaling pathway (P00036), T-cell activation (P00053), Toll receptor signaling pathway (P00054) | |
| down | 934 | n/a | ||
| 70 pi | up | 1017 | Apoptosis signaling pathway (P00006), B-cell activation (P00010), Inflammation mediated by chemokine and cytokine signaling pathway (P00031), Interleukin signaling pathway (P00036), Plasminogen activating cascade (P00050), Toll receptor signaling pathway (P00054) | |
| down | 1056 | n/a | ||
| 98 pi | up | 1091 | Apoptosis signaling pathway (P00006), B-cell activation (P00010), Inflammation mediated by chemokine and cytokine signaling pathway (P00031), Interleukin signaling pathway (P00036), JAK/STAT signaling pathway (P00038), Plasminogen activating cascade (P00050), Toll receptor signaling pathway (P00054) | |
| down | 982 | n/a | ||
| 120 pi | up | 1084 | Apoptosis signaling pathway (P00006), B-cell activation (P00010), Cadherin signaling pathway (P00012), Inflammation mediated by chemokine and cytokine signaling pathway (P00031), Interleukin signaling pathway (P00036), JAK/STAT signaling pathway (P00038), Plasminogen activating cascade (P00050), Toll receptor signaling pathway (P00054) | |
| down | 989 | n/a | ||
|
| ||||
| cerebrum | 14 pi | up | 150 | n/a |
| down | 70 | n/a | ||
| 28 pi | up | 165 | n/a | |
| down | 55 | n/a | ||
| 70 pi | up | 168 | n/a | |
| down | 52 | n/a | ||
| 98 pi | up | 158 | n/a | |
| down | 62 | n/a | ||
| 120 pi | up | 142 | n/a | |
| down | 78 | n/a | ||
| cerebellum | 14 pi | up | 163 | n/a |
| down | 52 | n/a | ||
| 28 pi | up | 161 | n/a | |
| down | 54 | n/a | ||
| 70 pi | up | 161 | n/a | |
| down | 54 | n/a | ||
| 98 pi | up | 161 | n/a | |
| down | 54 | n/a | ||
| 120 pi | up | 160 | n/a | |
| down | 55 | n/a |
n/a: no significantly enriched biological modules.